Sabby Management’s Trillium Therapeutics Inc. TRIL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q4 | – | Sell |
-70,000
| Closed | -$1.23M | – | 154 |
|
2021
Q3 | $1.23M | Sell |
70,000
-73,496
| -51% | -$1.29M | 0.17% | 39 |
|
2021
Q2 | $1.39M | Sell |
143,496
-56,073
| -28% | -$544K | 0.2% | 34 |
|
2021
Q1 | $2.14M | Buy |
199,569
+79,573
| +66% | +$854K | 0.42% | 23 |
|
2020
Q4 | $1.77M | Buy |
+119,996
| New | +$1.77M | 0.34% | 11 |
|
2020
Q3 | – | Hold |
0
| – | – | – | 114 |
|
2020
Q2 | – | Sell |
-287,906
| Closed | -$1.16M | – | 98 |
|
2020
Q1 | $1.16M | Buy |
+287,906
| New | +$1.16M | 0.48% | 7 |
|
2016
Q2 | – | Sell |
-14,137
| Closed | -$131K | – | 225 |
|
2016
Q1 | $131K | Buy |
+14,137
| New | +$131K | 0.01% | 156 |
|